104 related articles for article (PubMed ID: 22006751)
21. [Postoperative adjuvant therapy for 189 patients with completely resected non-small cell lung cancer of stage III(A)].
Li Q; Gao JM; Liang PY; Xie FY; Liu GZ
Ai Zheng; 2004 Nov; 23(11 Suppl):1463-6. PubMed ID: 15566658
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
[TBL] [Abstract][Full Text] [Related]
23. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
[TBL] [Abstract][Full Text] [Related]
24. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
25. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
Hitt R; López-Pousa A; Martínez-Trufero J; Escrig V; Carles J; Rizo A; Isla D; Vega ME; Martí JL; Lobo F; Pastor P; Valentí V; Belón J; Sánchez MA; Chaib C; Pallarés C; Antón A; Cervantes A; Paz-Ares L; Cortés-Funes H
J Clin Oncol; 2005 Dec; 23(34):8636-45. PubMed ID: 16275937
[TBL] [Abstract][Full Text] [Related]
26. Patterns and relevant factors of tumor recurrence for extrahepatic bile duct carcinoma after radical resection.
Park SW; Park YS; Chung JB; Kang JK; Kim KS; Choi JS; Lee WJ; Kim BR; Song SY
Hepatogastroenterology; 2004; 51(60):1612-8. PubMed ID: 15532789
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant therapy for ampullary carcinomas: the Mayo Clinic experience.
Bhatia S; Miller RC; Haddock MG; Donohue JH; Krishnan S
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):514-9. PubMed ID: 16863684
[TBL] [Abstract][Full Text] [Related]
28. Gallbladder carcinoma: a 28 year experience.
Frezza EE; Mezghebe H
Int Surg; 1997; 82(3):295-300. PubMed ID: 9372378
[TBL] [Abstract][Full Text] [Related]
29. [Significance of positive ductal margin and prognostic factors of surgical resection in middle and distal bile duct carcinoma].
Liang JW; Zhao P; Zhou ZX; Tian YT; Zhao DB; Wang CF
Zhonghua Wai Ke Za Zhi; 2009 May; 47(9):677-80. PubMed ID: 19615237
[TBL] [Abstract][Full Text] [Related]
30. Trimodality therapy for advanced gallbladder cancer.
Sasson AR; Hoffman JP; Ross E; Meropol NJ; Szarka CE; Freedman G; Pinover W; Pingpank JF; Eisenberg BL
Am Surg; 2001 Mar; 67(3):277-83; discussion 284. PubMed ID: 11270889
[TBL] [Abstract][Full Text] [Related]
31. Role of adjuvant chemoradiotherapy for resected extrahepatic biliary tract cancer.
Kim TH; Han SS; Park SJ; Lee WJ; Woo SM; Moon SH; Yoo T; Kim SS; Kim SH; Hong EK; Kim DY; Park JW
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e853-9. PubMed ID: 21497455
[TBL] [Abstract][Full Text] [Related]
32. Is extended hemihepatectomy plus pancreaticoduodenectomy justified for advanced bile duct cancer and gallbladder cancer?
Sakamoto Y; Nara S; Kishi Y; Esaki M; Shimada K; Kokudo N; Kosuge T
Surgery; 2013 Jun; 153(6):794-800. PubMed ID: 23415082
[TBL] [Abstract][Full Text] [Related]
33. Outcome of adjuvant therapy in biliary tract cancers.
McNamara MG; Walter T; Horgan AM; Amir E; Cleary S; McKeever EL; Min T; Wallace E; Hedley D; Krzyzanowska M; Moore M; Gallinger S; Greig P; Serra S; Dawson LA; Knox JJ
Am J Clin Oncol; 2015 Aug; 38(4):382-7. PubMed ID: 24572429
[TBL] [Abstract][Full Text] [Related]
34. Cancers of the gallbladder and biliary ducts.
Yee K; Sheppard BC; Domreis J; Blanke CD
Oncology (Williston Park); 2002 Jul; 16(7):939-46, 949; discussion 949-50, 952-3, 956-7. PubMed ID: 12164560
[TBL] [Abstract][Full Text] [Related]
35. Postoperative radiotherapy for gallbladder cancer.
Jeong Y; Park JH; Lee YJ; Park KM; Hwang S; Chang HM; Kim KP; Yoon SM; Jung NH; Kim JH
Anticancer Res; 2014 Oct; 34(10):5621-9. PubMed ID: 25275065
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant radiation therapy in gall bladder cancers: 10 years experience at Tata Memorial Hospital.
Mahantshetty UM; Palled SR; Engineer R; Homkar G; Shrivastava SK; Shukla PJ
J Cancer Res Ther; 2006; 2(2):52-6. PubMed ID: 17998675
[TBL] [Abstract][Full Text] [Related]
37. Defining the role of adjuvant therapy: cholangiocarcinoma and gall bladder cancer.
Williams TM; Majithia L; Wang SJ; Thomas CR
Semin Radiat Oncol; 2014 Apr; 24(2):94-104. PubMed ID: 24635866
[TBL] [Abstract][Full Text] [Related]
38. Neither neoadjuvant nor adjuvant therapy increases survival after biliary tract cancer resection with wide negative margins.
Glazer ES; Liu P; Abdalla EK; Vauthey JN; Curley SA
J Gastrointest Surg; 2012 Sep; 16(9):1666-71. PubMed ID: 22777053
[TBL] [Abstract][Full Text] [Related]
39. Radiotherapy of carcinomas of the extrahepatic biliary system.
Pilepich MV; Lambert PM
Radiology; 1978 Jun; 127(3):767-70. PubMed ID: 78508
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis.
Horgan AM; Amir E; Walter T; Knox JJ
J Clin Oncol; 2012 Jun; 30(16):1934-40. PubMed ID: 22529261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
